IP Library Granted Patent US 10,493,066
Granted Patent B2
US 10,493,066 · App. 15/711,754 · Granted Dec 3, 2019

Fumarate analogs and uses thereof

Inventors: Matthew Duncton (San Bruno, CA); Somasekhar Bhamidipati (Foster City, CA); Jiaxin Yu (Foster City, CA); Ihab Darwish (San Carlos, CA); Rajinder Singh (Belmont, CA)
Assignee: Rigel Pharmaceuticals, Inc.
A61K31/4439A61K31/41C07D257/04C07D401/04C07D403/12C07D405/04C07D405/06Y02A50/411Y02A50/414
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,493,066
App. No.
15/711,754
Granted
Dec 3, 2019
Kind
B2
Abstract

Aspects of the present disclosure include compounds that find use for the treatment of a variety of autoimmune and inflammatory diseases and disorders. Embodiments of the present disclosure also relate to pharmaceutical compositions that include these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Claims (7)

1. A method of treating a disease or disorder in a subject in need thereof, the method comprising:

administering to the subject a pharmaceutically effective amount of a compound selected from the group consisting of:

or a salt or stereoisomer thereof,

wherein the administering is sufficient to treat the disease or disorder, and

wherein the disease or disorder is multiple sclerosis.

2. The method of claim 1 , wherein the compound is

3. The method of claim 1 , wherein the compound is

Assignments (2)
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2017
From: DUNCTON, MATTHEW; BHAMIDIPATI, SOMASEKHAR; YU, JIAXIN; DARWISH, IHAB; SINGH, RAJINDER
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 044181/0845 →
Continuity (4)
Continuation 15269233 · Sep 19, 2016
Continuation 14815589 · Jul 31, 2015
Provisional Application 62033023 · Aug 4, 2014
Related Publication 20180071271A1 · Mar 15, 2018